People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Biotechnology, HR / Worktech, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Windtree Therapeutics Inc /De/ | — | Biotechnology | Series B | $104.5M | $1.0B | 2019 |
| WorkForce Software Holdings, LLC | — | HR / Worktech | Series C | $104.4M | $1.6B | 2016 |
| Myrtelle Inc. | — | Biotechnology | Series B | $73.2M | $117.0M | 2022 |
| Human Longevity, Inc. | — | Biotechnology | Series B | $59.0M | $398.9M | 2023 |
| Yaupon Therapeutics Inc | — | Pharmaceuticals | Series A | $21.6M | $256.8M | 2009 |
James Huang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Huang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ryan Hinkle | 1 | 20 |
| Peter Sobiloff | 1 | 13 |
| Betsy Atkins | 1 | 10 |
| Albert Cha | 1 | 9 |
| Stephen Tullman | 1 | 7 |
| Daniel Geffken | 1 | 6 |
| Ross Devor | 1 | 6 |
| Bruce Peacock | 1 | 5 |
| Michael Morini | 1 | 5 |
| Douglas Gessl | 1 | 4 |
| Thomas Barton | 1 | 4 |
| Wei-Wu He | 1 | 4 |
| Peter Jackson | 1 | 4 |
| Kamil Ali-Jackson | 1 | 3 |
| W. Thomas Amick | 1 | 3 |
| Greg Vontz | 1 | 3 |
| Joseph M. Mahady | 1 | 3 |
| James Hu | 1 | 3 |
| Isaac Kim | 1 | 3 |
| Bob Feller | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.